These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

544 related items for PubMed ID: 24911558

  • 1. Spectrum of complement-mediated thrombotic microangiopathies: pathogenetic insights identifying novel treatment approaches.
    Riedl M, Fakhouri F, Le Quintrec M, Noone DG, Jungraithmayr TC, Fremeaux-Bacchi V, Licht C.
    Semin Thromb Hemost; 2014 Jun; 40(4):444-64. PubMed ID: 24911558
    [Abstract] [Full Text] [Related]

  • 2. An update for atypical haemolytic uraemic syndrome: diagnosis and treatment. A consensus document.
    Campistol JM, Arias M, Ariceta G, Blasco M, Espinosa L, Espinosa M, Grinyó JM, Macía M, Mendizábal S, Praga M, Román E, Torra R, Valdés F, Vilalta R, Rodríguez de Córdoba S.
    Nefrologia; 2015 Jun; 35(5):421-47. PubMed ID: 26456110
    [Abstract] [Full Text] [Related]

  • 3. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report.
    Sengul Samanci N, Ayer M, Ergen A, Ozturk S.
    Transfus Apher Sci; 2015 Jun; 52(3):314-6. PubMed ID: 25634788
    [Abstract] [Full Text] [Related]

  • 4. Atypical hemolytic uremic syndrome in the setting of complement-amplifying conditions: case reports and a review of the evidence for treatment with eculizumab.
    Asif A, Nayer A, Haas CS.
    J Nephrol; 2017 Jun; 30(3):347-362. PubMed ID: 27848226
    [Abstract] [Full Text] [Related]

  • 5. Treatment of atypical hemolytic uremic syndrome and thrombotic microangiopathies: a focus on eculizumab.
    Schmidtko J, Peine S, El-Housseini Y, Pascual M, Meier P.
    Am J Kidney Dis; 2013 Feb; 61(2):289-99. PubMed ID: 23141475
    [Abstract] [Full Text] [Related]

  • 6. Two cases of kidney transplantation-associated thrombotic microangiopathy successfully treated with eculizumab.
    Ikeda T, Okumi M, Unagami K, Kanzawa T, Sawada A, Kawanishi K, Omoto K, Ishida H, Tanabe K.
    Nephrology (Carlton); 2016 Jul; 21 Suppl 1():35-40. PubMed ID: 26970541
    [Abstract] [Full Text] [Related]

  • 7. Complement activation in diseases presenting with thrombotic microangiopathy.
    Meri S.
    Eur J Intern Med; 2013 Sep; 24(6):496-502. PubMed ID: 23743117
    [Abstract] [Full Text] [Related]

  • 8. Distal Angiopathy and Atypical Hemolytic Uremic Syndrome: Clinical and Functional Properties of an Anti-Factor H IgAλ Antibody.
    Rigothier C, Delmas Y, Roumenina LT, Contin-Bordes C, Lepreux S, Bridoux F, Goujon JM, Bachelet T, Touchard G, Frémeaux-Bacchi V, Combe C.
    Am J Kidney Dis; 2015 Aug; 66(2):331-6. PubMed ID: 26015278
    [Abstract] [Full Text] [Related]

  • 9. Complement Activation and Thrombotic Microangiopathies.
    Palomo M, Blasco M, Molina P, Lozano M, Praga M, Torramade-Moix S, Martinez-Sanchez J, Cid J, Escolar G, Carreras E, Paules C, Crispi F, Quintana LF, Poch E, Rodas L, Goma E, Morelle J, Espinosa M, Morales E, Avila A, Cabello V, Ariceta G, Chocron S, Manrique J, Barros X, Martin N, Huerta A, Fraga-Rodriguez GM, Cao M, Martin M, Romera AM, Moreso F, Manonelles A, Gratacos E, Pereira A, Campistol JM, Diaz-Ricart M.
    Clin J Am Soc Nephrol; 2019 Dec 06; 14(12):1719-1732. PubMed ID: 31694864
    [Abstract] [Full Text] [Related]

  • 10. Diagnosis and management of complement mediated thrombotic microangiopathies.
    Cataland SR, Wu HM.
    Blood Rev; 2014 Mar 06; 28(2):67-74. PubMed ID: 24534133
    [Abstract] [Full Text] [Related]

  • 11. A case-based narrative review of pregnancy-associated atypical hemolytic uremic syndrome/complement-mediated thrombotic microangiopathy.
    Che M, Moran SM, Smith RJ, Ren KYM, Smith GN, Shamseddin MK, Avila-Casado C, Garland JS.
    Kidney Int; 2024 May 06; 105(5):960-970. PubMed ID: 38408703
    [Abstract] [Full Text] [Related]

  • 12. [Atypical hemolytic uremic syndrome (aHUS): new insights into pathogenesis leading to novel therapeutic approaches].
    Kistler AD.
    Praxis (Bern 1994); 2016 Mar 30; 105(7):389-96. PubMed ID: 27005733
    [Abstract] [Full Text] [Related]

  • 13. Therapeutic complement inhibition in complement-mediated hemolytic anemias: Past, present and future.
    Risitano AM, Marotta S.
    Semin Immunol; 2016 Jun 30; 28(3):223-40. PubMed ID: 27346521
    [Abstract] [Full Text] [Related]

  • 14. A retrospective study of pregnancy-associated atypical hemolytic uremic syndrome.
    Huerta A, Arjona E, Portoles J, Lopez-Sanchez P, Rabasco C, Espinosa M, Cavero T, Blasco M, Cao M, Manrique J, Cabello-Chavez V, Suñer M, Heras M, Fulladosa X, Belmar L, Sempere A, Peralta C, Castillo L, Arnau A, Praga M, Rodriguez de Cordoba S.
    Kidney Int; 2018 Feb 30; 93(2):450-459. PubMed ID: 28911789
    [Abstract] [Full Text] [Related]

  • 15. Prevention and treatment of atypical haemolytic uremic syndrome after kidney transplantation.
    Okumi M, Tanabe K.
    Nephrology (Carlton); 2016 Jul 30; 21 Suppl 1():9-13. PubMed ID: 26988663
    [Abstract] [Full Text] [Related]

  • 16. Genetics of atypical hemolytic uremic syndrome (aHUS).
    Rodríguez de Córdoba S, Hidalgo MS, Pinto S, Tortajada A.
    Semin Thromb Hemost; 2014 Jun 30; 40(4):422-30. PubMed ID: 24799305
    [Abstract] [Full Text] [Related]

  • 17. [Hemolytic and uremic syndrome and related thrombotic microangiopathies: Treatment and prognosis].
    Rafat C, Coppo P, Fakhouri F, Frémeaux-Bacchi V, Loirat C, Zuber J, Rondeau E.
    Rev Med Interne; 2017 Dec 30; 38(12):833-839. PubMed ID: 28947259
    [Abstract] [Full Text] [Related]

  • 18. Secondary thrombotic microangiopathy and eculizumab: A reasonable therapeutic option.
    Román E, Mendizábal S, Jarque I, de la Rubia J, Sempere A, Morales E, Praga M, Ávila A, Górriz JL.
    Nefrologia; 2017 Dec 30; 37(5):478-491. PubMed ID: 28946961
    [Abstract] [Full Text] [Related]

  • 19. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome.
    Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, Bingham C, Cohen DJ, Delmas Y, Douglas K, Eitner F, Feldkamp T, Fouque D, Furman RR, Gaber O, Herthelius M, Hourmant M, Karpman D, Lebranchu Y, Mariat C, Menne J, Moulin B, Nürnberger J, Ogawa M, Remuzzi G, Richard T, Sberro-Soussan R, Severino B, Sheerin NS, Trivelli A, Zimmerhackl LB, Goodship T, Loirat C.
    N Engl J Med; 2013 Jun 06; 368(23):2169-81. PubMed ID: 23738544
    [Abstract] [Full Text] [Related]

  • 20. Eculizumab is a safe and effective treatment in pediatric patients with atypical hemolytic uremic syndrome.
    Greenbaum LA, Fila M, Ardissino G, Al-Akash SI, Evans J, Henning P, Lieberman KV, Maringhini S, Pape L, Rees L, van de Kar NC, Vande Walle J, Ogawa M, Bedrosian CL, Licht C.
    Kidney Int; 2016 Mar 06; 89(3):701-11. PubMed ID: 26880462
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.